Literature DB >> 31237232

Early Mortality among Immunocompetent Patients of Tuberculous Meningitis: A Prospective Study.

Ravi Shekhar Jaipuriar1, Ravindra Kumar Garg1, Imran Rizvi1, Hardeep Singh Malhotra1, Neeraj Kumar1, Amita Jain2, Rajesh Verma1, Praveen Kumar Sharma1, Shweta Pandey1, Ravi Uniyal1.   

Abstract

Most deaths in tuberculous meningitis occur in the early part of the illness. We assessed the determinants of early deaths, occurring within 2 months of intensive therapy. We prospectively included consecutive newly diagnosed adults with HIV-negative tuberculous meningitis. Patients were given WHO-recommended antituberculosis treatment and were followed up for 9 months. We enrolled 152 patients. A total of 26 deaths were recorded during 2 months. The logistic regression analysis revealed that papilledema (P = 0.029, odds ratio (OR) = 4.8 [1.2-19.8]), increasing age (P = 0.001, OR = 1.07 [1.03-1.1]), stage-III disease (Glasgow coma scale score ≤ 10; P = 0.01, OR = 4.2 [1.4-12.3]), and hydrocephalus (P = 0.003, OR = 8.4 [2.1-33.6]) were independently associated with death. In addition, cerebral infarcts (P = 0.012, OR = 5.6 [1.5-21.3]), paraparesis (P = 0.004, OR = 8.8 [2.02-38.1]), and age (P = 0.005, OR = 1.05 [1.02-1.09]) were associated with poor functional outcome. In conclusion, disease severity predicts early deaths in tuberculous meningitis.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31237232      PMCID: PMC6685555          DOI: 10.4269/ajtmh.19-0098

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  19 in total

1.  Predictors of mortality in patients with meningeal tuberculosis.

Authors:  Elizabeth Litta George; Thomas Iype; Ajith Cherian; Sinchu Chandy; Aswini Kumar; Ajitha Balakrishnan; K Vijayakumar
Journal:  Neurol India       Date:  2012 Jan-Feb       Impact factor: 2.117

2.  FUNCTIONAL EVALUATION: THE BARTHEL INDEX.

Authors:  F I MAHONEY; D W BARTHEL
Journal:  Md State Med J       Date:  1965-02

3.  Death and disability: the outcomes of tuberculous meningitis.

Authors:  Stephen M Graham; Peter R Donald
Journal:  Lancet Infect Dis       Date:  2014-08-06       Impact factor: 25.071

4.  Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial.

Authors:  U K Misra; J Kalita; P P Nair
Journal:  J Neurol Sci       Date:  2010-04-24       Impact factor: 3.181

5.  Tuberculous meningitis: a uniform case definition for use in clinical research.

Authors:  Suzaan Marais; Guy Thwaites; Johan F Schoeman; M Estée Török; Usha K Misra; Kameshwar Prasad; Peter R Donald; Robert J Wilkinson; Ben J Marais
Journal:  Lancet Infect Dis       Date:  2010-09-06       Impact factor: 25.071

6.  Mortality in hospitalized patients with tuberculous meningitis.

Authors:  Jaime Soria; Tatiana Metcalf; Nicanor Mori; Renee E Newby; Silvia M Montano; Luz Huaroto; Eduardo Ticona; Joseph R Zunt
Journal:  BMC Infect Dis       Date:  2019-01-05       Impact factor: 3.090

Review 7.  Tuberculous meningitis.

Authors:  Robert J Wilkinson; Ursula Rohlwink; Usha Kant Misra; Reinout van Crevel; Nguyen Thi Hoang Mai; Kelly E Dooley; Maxine Caws; Anthony Figaji; Rada Savic; Regan Solomons; Guy E Thwaites
Journal:  Nat Rev Neurol       Date:  2017-09-08       Impact factor: 42.937

8.  Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis.

Authors:  A Dorothee Heemskerk; Nguyen D Bang; Nguyen T H Mai; Tran T H Chau; Nguyen H Phu; Pham P Loc; Nguyen V V Chau; Tran T Hien; Nguyen H Dung; Nguyen T N Lan; Nguyen H Lan; Nguyen N Lan; Le T Phong; Nguyen N Vien; Nguyen Q Hien; Nguyen T B Yen; Dang T M Ha; Jeremy N Day; Maxine Caws; Laura Merson; Tran T V Thinh; Marcel Wolbers; Guy E Thwaites; Jeremy J Farrar
Journal:  N Engl J Med       Date:  2016-01-14       Impact factor: 91.245

9.  Prognostic Models for 9-Month Mortality in Tuberculous Meningitis.

Authors:  Le Thi Phuong Thao; A Dorothee Heemskerk; Ronald B Geskus; Nguyen Thi Hoang Mai; Dang Thi Minh Ha; Tran Thi Hong Chau; Nguyen Hoan Phu; Nguyen Van Vinh Chau; Maxine Caws; Nguyen Huu Lan; Do Dang Anh Thu; Nguyen Thuy Thuong Thuong; Jeremy Day; Jeremy J Farrar; M Estee Torok; Nguyen Duc Bang; Guy E Thwaites; Marcel Wolbers
Journal:  Clin Infect Dis       Date:  2018-02-01       Impact factor: 9.079

10.  Pretreatment Cerebrospinal Fluid Bacterial Load Correlates With Inflammatory Response and Predicts Neurological Events During Tuberculous Meningitis Treatment.

Authors:  Nguyen T T Thuong; Dao N Vinh; Hoang T Hai; Do D A Thu; Le T H Nhat; Dorothee Heemskerk; Nguyen D Bang; Maxine Caws; Nguyen T H Mai; Guy E Thwaites
Journal:  J Infect Dis       Date:  2019-02-23       Impact factor: 5.226

View more
  5 in total

1.  Risk factors for poor outcome in childhood tuberculous meningitis.

Authors:  Mao-Shui Wang; Mei Zhao; Xin-Jie Liu
Journal:  Sci Rep       Date:  2021-04-21       Impact factor: 4.379

Review 2.  Neutrophil-Mediated Immunopathology and Matrix Metalloproteinases in Central Nervous System - Tuberculosis.

Authors:  Xuan Ying Poh; Fei Kean Loh; Jon S Friedland; Catherine W M Ong
Journal:  Front Immunol       Date:  2022-01-12       Impact factor: 7.561

3.  High-dose rifampin improves bactericidal activity without increased intracerebral inflammation in animal models of tuberculous meningitis.

Authors:  Camilo A Ruiz-Bedoya; Filipa Mota; Elizabeth W Tucker; Farina J Mahmud; Maria I Reyes-Mantilla; Clara Erice; Melissa Bahr; Kelly Flavahan; Patricia de Jesus; John Kim; Catherine A Foss; Charles A Peloquin; Dima A Hammoud; Alvaro A Ordonez; Carlos A Pardo; Sanjay K Jain
Journal:  J Clin Invest       Date:  2022-03-15       Impact factor: 14.808

4.  Normal cerebrospinal fluid protein and associated clinical characteristics in children with tuberculous meningitis.

Authors:  Jun-Li Wang; Chao Han; Feng-Lian Yang; Mao-Shui Wang; Yu He
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

5.  Authors' Response.

Authors:  Hardeep Singh Malhotra; Ravindra Kumar Garg; Ravi Shekhar Jaipuriar; Imran Rizvi; Neeraj Kumar
Journal:  Am J Trop Med Hyg       Date:  2019-11       Impact factor: 2.345

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.